|

SAR448501 Clinical Trials

2 actively recruiting trials

Also known as: DR-0201

Pipeline

Phase 1: 2

Top Sponsors

  • Sanofi2

Indications

  • Diffuse Cutaneous Systemic Sclerosis1
  • dcSSc1
  • SSc, Diffuse Sclerosis1
  • Polymyositis1
  • Primary Sjögren Syndrome1

Other2 trials

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
Phase 1
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.